| PERIOD ENDING | 30-Sep-04 | 30-Jun-04 | 31-Mar-04 | 31-Dec-03 | | Total Revenue | 23,109 | 26,155 | 23,444 | 28,591 | | Cost of Revenue |
-
| 50,026 | (25,651) | 11,799 | | | Gross Profit | 23,109 | (23,871) | 49,095 | 16,792 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 41,645 | 4,783 | 78,012 | 42,051 | | Non Recurring |
-
|
-
|
-
| (5,687) | | Others | 117 | 2,762 | 4,876 | 3,814 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,653) | (31,416) | (33,793) | (23,386) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,018) | 2,561 |
-
|
-
| | Earnings Before Interest And Taxes | (20,671) | (28,855) | (33,793) | (23,386) | | Interest Expense | 18,155 | 17,769 | 16,901 | 16,650 | | Income Before Tax | (38,826) | (46,624) | (50,694) | (40,036) | | Income Tax Expense | (13,589) | (17,717) | (19,263) | (15,214) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,237) | (28,907) | (31,431) | (24,822) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (25,237) | (28,907) | (31,431) | (24,822) | | Preferred Stock And Other Adjustments | (3,475) | (1,967) | (1,751) |
-
| | | Net Income Applicable To Common Shares | ($28,712) | ($30,874) | ($33,182) | ($24,822) |
|
0.47% Nasdaq 
Income Statement
